Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100656462 | 10065646 | 2 | F | 2014 | 20150319 | 20140408 | 20150331 | PER | US-PFIZER INC-2014094099 | PFIZER | 55.00 | YR | M | Y | 0.00000 | 20150331 | N | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100656462 | 10065646 | 1 | PS | INLYTA | AXITINIB | 1 | 5 MG, 2X/DAY | D | H64327 | 202324 | 5 | MG | FILM-COATED TABLET | BID | |||||
| 100656462 | 10065646 | 2 | SS | INLYTA | AXITINIB | 1 | 3 MG, 2X/DAY | D | 202324 | 3 | MG | FILM-COATED TABLET | BID | ||||||
| 100656462 | 10065646 | 3 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 300 MG | D | 0 | TABLET | |||||||||
| 100656462 | 10065646 | 4 | C | AZITHROMYCIN | AZITHROMYCIN ANHYDROUS | 1 | 250 MG | D | 0 | TABLET | |||||||||
| 100656462 | 10065646 | 5 | C | LISINOPRIL. | LISINOPRIL | 1 | 5 MG | D | 0 | TABLET | |||||||||
| 100656462 | 10065646 | 6 | C | MEGACE | MEGESTROL ACETATE | 1 | 40 MG/ML (400 MG/10 ML) | D | 0 | ORAL SUSPENSION | |||||||||
| 100656462 | 10065646 | 7 | C | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | 20 MG | D | 0 | TABLET | |||||||||
| 100656462 | 10065646 | 8 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | 25 MG | D | 0 | TABLET | |||||||||
| 100656462 | 10065646 | 9 | C | VITAMIN C | ASCORBIC ACID | 1 | 500 MG | D | 0 | TABLET | |||||||||
| 100656462 | 10065646 | 10 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | (120 MG-1000 UNIT-10 MG TAB) | D | 0 | TABLET | |||||||||
| 100656462 | 10065646 | 11 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | 10 MG | D | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100656462 | 10065646 | 1 | Metastatic renal cell carcinoma |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100656462 | 10065646 | Anxiety | |
| 100656462 | 10065646 | Blood pressure increased | |
| 100656462 | 10065646 | Blood thyroid stimulating hormone increased | |
| 100656462 | 10065646 | Decreased appetite | |
| 100656462 | 10065646 | Depression | |
| 100656462 | 10065646 | Diarrhoea | |
| 100656462 | 10065646 | Fatigue | |
| 100656462 | 10065646 | Nodule | |
| 100656462 | 10065646 | Palmar-plantar erythrodysaesthesia syndrome | |
| 100656462 | 10065646 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100656462 | 10065646 | 1 | 20140320 | 0 |